🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Biological therapies, such as hu14.18-interleukin-2 fusion prote...
Status
Completed
Location
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Start Date
2005-05
Trial ID
NCT00109863
Treatments Being Tested
Subjects with relapsed or refractory neuroblastoma and osteosarcoma will re...
Status
Withdrawn
Location
University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics
Start Date
2018-03-12
Trial ID
NCT03209869
Treatments Being Tested
RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protei...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2005-08
Trial ID
NCT00082758
Treatments Being Tested
RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protei...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2001-10
Trial ID
NCT00003750
Treatments Being Tested
This phase I/II trial is designed to determine the maximum tolerated dose o...
Status
Terminated
Location
University of Wisconsin Carbone Cancer Center
Start Date
2020-01-30
Trial ID
NCT03958383
Treatments Being Tested
Evaluate the antitumor activity of hu14.18-IL2 in the minimal residual dise...
Status
Completed
Location
University of Wisconsin Hospitals and Clinics
Start Date
2007-12-17
Trial ID
NCT00590824
Treatments Being Tested
This phase II trial is studying how well hu14.18-interleukin-2 (IL2) fusion...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-09
Trial ID
NCT01334515
Treatments Being Tested